A double-blind placebo-controlled discontinuation study of zuclopenthixol for the treatment of aggressive disruptive behaviours in adults with mental retardation - secondary parameter analyses.

@article{Hler2008ADP,
  title={A double-blind placebo-controlled discontinuation study of zuclopenthixol for the treatment of aggressive disruptive behaviours in adults with mental retardation - secondary parameter analyses.},
  author={Frank Walter H{\"a}\ssler and Thomas Glaser and {\'A}kos Ferenc Pap and Manfred Beneke and Albert Diefenbacher and Olaf Reis},
  journal={Pharmacopsychiatry},
  year={2008},
  volume={41 6},
  pages={232-9}
}
INTRODUCTION Earlier studies showed risperidone to be effective in the treatment of aggression and self-injurious behaviour in adults with mental retardation but also having adverse side effects. This study was conducted to evaluate the effects of zuclopenthixol withdrawal. METHODS After open treatment with zuclopenthixol (n=49) responders were randomly… CONTINUE READING